Pfizer, BioNTech Say Influenza Vaccine Candidate Met One of Two Primary Objectives in Phase 3 Trial
Pfizer, BioNTech Say Influenza Vaccine Candidate Met One of Two Primary Objectives in Phase 3 Trial
輝瑞、biontech表示流感疫苗候選疫苗已經在第三階段試驗中實現了兩個主要目標中的一個。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊